US Stock MarketDetailed Quotes

RAPP Rapport Therapeutics

Watchlist
  • 9.780
  • -0.150-1.51%
Close Mar 19 16:00 ET
  • 9.440
  • -0.340-3.48%
Post 20:01 ET
356.94MMarket Cap-4.57P/E (TTM)

Rapport Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(FY)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
107.00%305.28M
107.00%305.28M
--320.66M
--336.14M
--193.24M
373.31%147.48M
--147.48M
--31.16M
-Cash and cash equivalents
-19.05%56.81M
-19.05%56.81M
--39.31M
--110.16M
--74.27M
125.20%70.17M
--70.17M
--31.16M
-Short-term investments
221.41%248.48M
221.41%248.48M
--281.35M
--225.98M
--118.98M
--77.31M
--77.31M
--0
Restricted cash
23.53%105K
23.53%105K
--105K
--105K
--105K
--85K
--85K
--0
Other current assets
33.48%4.42M
33.48%4.42M
--5.17M
--4.42M
--5.38M
2,935.78%3.31M
--3.31M
--109K
Total current assets
105.34%309.8M
105.34%309.8M
--325.94M
--340.67M
--198.73M
382.51%150.87M
--150.87M
--31.27M
Non current assets
Net PPE
24.28%4.97M
24.28%4.97M
--5.02M
--5.24M
--5.49M
1,094.03%4M
--4M
--335K
-Gross PPE
43.83%5.94M
43.83%5.94M
--5.72M
--5.73M
--5.77M
1,079.14%4.13M
--4.13M
--350K
-Accumulated depreciation
-659.84%-965K
-659.84%-965K
---705K
---485K
---279K
-746.67%-127K
---127K
---15K
Other non current assets
-70.96%160K
-70.96%160K
--189K
--189K
--2.07M
--551K
--551K
----
Total non current assets
12.74%5.13M
12.74%5.13M
--5.21M
--5.43M
--7.56M
1,258.51%4.55M
--4.55M
--335K
Total assets
102.63%314.93M
102.63%314.93M
--331.14M
--346.1M
--206.29M
391.80%155.42M
--155.42M
--31.6M
Liabilities
Current liabilities
Payables
-21.90%1.95M
-21.90%1.95M
--1.32M
--1.88M
--1.45M
72.55%2.5M
--2.5M
--1.45M
-accounts payable
-21.90%1.95M
-21.90%1.95M
--1.32M
--1.88M
--1.45M
72.55%2.5M
--2.5M
--1.45M
Current accrued expenses
-26.41%2.37M
-26.41%2.37M
--1.83M
--3.81M
--6.71M
1,410.80%3.22M
--3.22M
--213K
Current debt and capital lease obligation
10.00%737K
10.00%737K
--720K
--703K
--686K
--670K
--670K
----
-Current capital lease obligation
10.00%737K
10.00%737K
--720K
--703K
--686K
--670K
--670K
--0
Current liabilities
-0.41%8.77M
-0.41%8.77M
--7.1M
--8.1M
--9.89M
429.34%8.8M
--8.8M
--1.66M
Non current liabilities
Long term debt and capital lease obligation
-49.93%739K
-49.93%739K
--931K
--1.12M
--1.3M
--1.48M
--1.48M
--0
-Long term capital lease obligation
-49.93%739K
-49.93%739K
--931K
--1.12M
--1.3M
--1.48M
--1.48M
--0
Preferred securities outside stock equity
--0
--0
--0
--0
--234.74M
326.92%170.78M
--170.78M
--40M
Total non current liabilities
-99.57%739K
-99.57%739K
--931K
--1.12M
--236.04M
330.61%172.25M
--172.25M
--40M
Total liabilities
-94.75%9.51M
-94.75%9.51M
--8.03M
--9.21M
--245.92M
334.55%181.06M
--181.06M
--41.67M
Shareholders'equity
Share capital
825.00%37K
825.00%37K
--36K
--36K
--4K
0.00%4K
--4K
--4K
-common stock
825.00%37K
825.00%37K
--36K
--36K
--4K
0.00%4K
--4K
--4K
-Preferred stock
--0
--0
--0
----
----
--0
--0
----
Retained earnings
-172.34%-123.75M
-172.34%-123.75M
---103.77M
---86.23M
---68.11M
-326.57%-45.44M
---45.44M
---10.65M
Paid-in capital
2,070.42%429.66M
2,070.42%429.66M
--426.44M
--423.26M
--28.63M
3,278.16%19.8M
--19.8M
--586K
Gains losses not affecting retained earnings
-13,150.00%-522K
-13,150.00%-522K
--400K
---183K
---160K
--4K
--4K
--0
Total stockholders'equity
1,291.49%305.43M
1,291.49%305.43M
--323.11M
--336.89M
---39.63M
-154.76%-25.63M
---25.63M
---10.06M
Total equity
1,291.49%305.43M
1,291.49%305.43M
--323.11M
--336.89M
---39.63M
-154.76%-25.63M
---25.63M
---10.06M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(FY)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 107.00%305.28M107.00%305.28M--320.66M--336.14M--193.24M373.31%147.48M--147.48M--31.16M
-Cash and cash equivalents -19.05%56.81M-19.05%56.81M--39.31M--110.16M--74.27M125.20%70.17M--70.17M--31.16M
-Short-term investments 221.41%248.48M221.41%248.48M--281.35M--225.98M--118.98M--77.31M--77.31M--0
Restricted cash 23.53%105K23.53%105K--105K--105K--105K--85K--85K--0
Other current assets 33.48%4.42M33.48%4.42M--5.17M--4.42M--5.38M2,935.78%3.31M--3.31M--109K
Total current assets 105.34%309.8M105.34%309.8M--325.94M--340.67M--198.73M382.51%150.87M--150.87M--31.27M
Non current assets
Net PPE 24.28%4.97M24.28%4.97M--5.02M--5.24M--5.49M1,094.03%4M--4M--335K
-Gross PPE 43.83%5.94M43.83%5.94M--5.72M--5.73M--5.77M1,079.14%4.13M--4.13M--350K
-Accumulated depreciation -659.84%-965K-659.84%-965K---705K---485K---279K-746.67%-127K---127K---15K
Other non current assets -70.96%160K-70.96%160K--189K--189K--2.07M--551K--551K----
Total non current assets 12.74%5.13M12.74%5.13M--5.21M--5.43M--7.56M1,258.51%4.55M--4.55M--335K
Total assets 102.63%314.93M102.63%314.93M--331.14M--346.1M--206.29M391.80%155.42M--155.42M--31.6M
Liabilities
Current liabilities
Payables -21.90%1.95M-21.90%1.95M--1.32M--1.88M--1.45M72.55%2.5M--2.5M--1.45M
-accounts payable -21.90%1.95M-21.90%1.95M--1.32M--1.88M--1.45M72.55%2.5M--2.5M--1.45M
Current accrued expenses -26.41%2.37M-26.41%2.37M--1.83M--3.81M--6.71M1,410.80%3.22M--3.22M--213K
Current debt and capital lease obligation 10.00%737K10.00%737K--720K--703K--686K--670K--670K----
-Current capital lease obligation 10.00%737K10.00%737K--720K--703K--686K--670K--670K--0
Current liabilities -0.41%8.77M-0.41%8.77M--7.1M--8.1M--9.89M429.34%8.8M--8.8M--1.66M
Non current liabilities
Long term debt and capital lease obligation -49.93%739K-49.93%739K--931K--1.12M--1.3M--1.48M--1.48M--0
-Long term capital lease obligation -49.93%739K-49.93%739K--931K--1.12M--1.3M--1.48M--1.48M--0
Preferred securities outside stock equity --0--0--0--0--234.74M326.92%170.78M--170.78M--40M
Total non current liabilities -99.57%739K-99.57%739K--931K--1.12M--236.04M330.61%172.25M--172.25M--40M
Total liabilities -94.75%9.51M-94.75%9.51M--8.03M--9.21M--245.92M334.55%181.06M--181.06M--41.67M
Shareholders'equity
Share capital 825.00%37K825.00%37K--36K--36K--4K0.00%4K--4K--4K
-common stock 825.00%37K825.00%37K--36K--36K--4K0.00%4K--4K--4K
-Preferred stock --0--0--0----------0--0----
Retained earnings -172.34%-123.75M-172.34%-123.75M---103.77M---86.23M---68.11M-326.57%-45.44M---45.44M---10.65M
Paid-in capital 2,070.42%429.66M2,070.42%429.66M--426.44M--423.26M--28.63M3,278.16%19.8M--19.8M--586K
Gains losses not affecting retained earnings -13,150.00%-522K-13,150.00%-522K--400K---183K---160K--4K--4K--0
Total stockholders'equity 1,291.49%305.43M1,291.49%305.43M--323.11M--336.89M---39.63M-154.76%-25.63M---25.63M---10.06M
Total equity 1,291.49%305.43M1,291.49%305.43M--323.11M--336.89M---39.63M-154.76%-25.63M---25.63M---10.06M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion----
Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.